Cite
HARVARD Citation
Quénéhervé, L. et al. (n.d.). P320 Confocal Laser Endomicroscopy to predict the efficacy of vedolizumab as first-line biotherapy in ulcerative colitis. Journal of Crohn's and colitis. pp. i460-i461. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Quénéhervé, L. et al. (n.d.). P320 Confocal Laser Endomicroscopy to predict the efficacy of vedolizumab as first-line biotherapy in ulcerative colitis. Journal of Crohn's and colitis. pp. i460-i461. [Online].